117b Complications of cirrhosis Flashcards
complications of cirrhosis
ascites and hepatic hydrothorax (through diaphragm via holes) HPS and HRS Varices --> bleeding encephalopathy (ammonia) HCC
where does cirrhosis damage occur in the liver that leads to portal HTN? What else contributes to ascites?
scarring in sinusoids –> portal HTN
arterial splanchnic vasodilation leads to blood pooling
stellate cells - location and role in cirrhosis
space of disse
lay down collagen from hepatic injury –> fibrosis –> cirrhosis
ascites development - pathogenesis and timeline of fluid build up
portal HTN –>
systemic + splanchnic vasodilation via NO –>
lowers renal perfusion –> increased RAAS, SNS, ADH –> retain salt and water –> fluid oozes from abdominal organs
fluid build up quickly
ascites and hepatic hydrothorax - what labs confirm that its from portal HTN?
- high SAAG (serum ascites albumin gradient) = serum albumin - ascites albumin
- lower protein (<2.5)
Ascites and Hepatic Hydrothorax - treatment + what should never be used?
1) salt < 2 g/day (usually not fluid restriction unless hyponatremic in late stages)
2) diuretics - lasix (furosemide) and aldactone (spironolactone)
3) paracentesis as needed
4) prophylaxis against SBP (spont bact peritonitis) in some patients
5) Use TIPS.
Never put in a chest tube OR drainage catheter in abdomen – high risk of infection without benefit
when should prophylaxis for SBP be considered?
GI bleeds Hostpialized patient (protein <1.5)
TIPS and what it does
Transjugular intrahepatic portosystemic shunt
bypasses liver sinusoids - reduces ascites by reducing portal HTN
hepatopulmonary syndrome - what happens in the lungs? what does this lead to?
intrapulmonary vascular dilations (IPVD) from NO at base of lung –> hypoxia due to ventilation/perfusion mismatch
HPS patient symptoms/findings and treatment
1) spider angiomata
2) orthodeoxia playpnea - sit up and get short of breath and deoxygenated
treatment - supplemental O2 and transplant (curative)
hepatorenal syndrome - pathogenesis and outcomes
cirrhosis –> portal HTN –> splanchnic and systemic vasodilation –> low effective circulating volume –> heart pumps harder (high output heart failure) + increased Na/water retention + kidney vasoconstriction
reversible
high risk of death
HRS treatment
1) hold diuretics
2) volume replacement with albumin -> increases kidney perfusion
3) if 48 hrs w/out improvement -> use cocktail
albumin
octreotide (reduces splanchnic vasodilation)
midodrine (a-agonist - systemic vasoconstrictor)
portal HTN - varices locations
esophageal
caput medusae
hemorrhoids
other locations
varices treatment goal and specific agents/procedures
goal is to reduce risk of bleeding
1) nonselective B-blockers (propran, nad, carved _olol) “PROPer CARVED NADs”
highest dose tolerable
B1+B2 (2=unopposed alpha reduces inflow via vasoconstriction, 1=slows heart and CO)
2) band ligation
variceal bleeding treatment
antibiotics
octreotide - reduces portal HTN via splan vasodilat
bands
TIPS for recurrent